Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Kenvue Inc (KVUE)

Kenvue Inc (KVUE)
23.02 +0.75 (+3.35%) 12:51 ET [NYSE]
23.00 x 168 23.01 x 200
Realtime by (Cboe BZX)
23.00 x 168 23.01 x 200
Realtime 22.27 unch (unch) 09:20 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
22.44
Day High
22.98
Open 22.56
Previous Close 22.27 22.27
Volume 8,384,538 8,384,538
Avg Vol 17,252,928 17,252,928
Stochastic %K 59.07% 59.07%
Weighted Alpha +19.75 +19.75
5-Day Change +0.31 (+1.34%) +0.31 (+1.34%)
52-Week Range 17.67 - 24.46 17.67 - 24.46
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,729,248
  • Shares Outstanding, K 1,918,691
  • Annual Sales, $ 15,455 M
  • Annual Income, $ 1,030 M
  • EBIT $ 1,841 M
  • EBITDA $ 2,463 M
  • 60-Month Beta 1.02
  • Price/Sales 2.90
  • Price/Cash Flow 15.90
  • Price/Book 4.64

Options Overview Details

View History
  • Implied Volatility 36.67% ( -3.14%)
  • Historical Volatility 31.51%
  • IV Percentile 86%
  • IV Rank 47.02%
  • IV High 57.53% on 02/05/25
  • IV Low 18.17% on 12/02/24
  • Put/Call Vol Ratio 0.19
  • Today's Volume 1,206
  • Volume Avg (30-Day) 14,854
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 286,482
  • Open Int (30-Day) 298,164

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.23
  • Number of Estimates 6
  • High Estimate 0.24
  • Low Estimate 0.21
  • Prior Year 0.28
  • Growth Rate Est. (year over year) -17.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.96 +9.80%
on 04/09/25
Period Open: 23.31
24.23 -5.01%
on 04/03/25
-0.30 (-1.27%)
since 03/21/25
3-Month
19.75 +16.53%
on 02/06/25
Period Open: 20.75
24.36 -5.52%
on 03/04/25
+2.26 (+10.92%)
since 01/22/25
52-Week
17.67 +30.25%
on 07/11/24
Period Open: 19.58
24.46 -5.91%
on 11/26/24
+3.43 (+17.54%)
since 04/22/24

Most Recent Stories

More News
Here's How You Should Play JNJ Stock After Q1 Earnings Beat

Earlier this week, J&J JNJ began the first-quarter earnings season for the drug and biotech sector with better-than-expected results.J&J’s first-quarter adjusted earnings were $2.77 per share, which...

JNJ : 157.37 (+0.29%)
KVUE : 23.01 (+3.32%)
TEVA : 13.98 (+5.03%)
AMGN : 276.85 (+1.16%)
This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row

Johnson & Johnson (NYSE: JNJ) continues to treat its investors like royalty. The healthcare behemoth recently gave them another raise, increasing its dividend payment by 4.8%. That extended its dividend...

JNJ : 157.37 (+0.29%)
KVUE : 23.01 (+3.32%)
JNJ Tops Q1 Earnings, Ups '25 Sales View to Include Intra-Cellular Deal

Johnson & Johnson’s JNJ first-quarter 2025 earnings came in at $2.77 per share, which beat the Zacks Consensus Estimate of $2.57. Earnings rose 2.2% from the year-ago period.Adjusted earnings exclude...

JNJ : 157.37 (+0.29%)
KVUE : 23.01 (+3.32%)
TEVA : 13.98 (+5.03%)
AMGN : 276.85 (+1.16%)
2 Under-the-Radar Consumer Staples Stocks With Big Dividends

Edgewell and Kenvue are under-the-radar consumer staples stocks poised to gain as the U.S. dollar declines. Learn why they may boost your income portfolio.

UUP : 27.15 (+0.41%)
JNJ : 157.37 (+0.29%)
KVUE : 23.01 (+3.32%)
EPC : 30.44 (+1.43%)
Buy, Sell or Hold J&J Stock? Key Tips Ahead of Q1 Earnings

Johnson & Johnson JNJ will begin the earnings season for the drug & biotech sector when it reports its first-quarter 2025 results on April 15. The Zacks Consensus Estimate for first-quarter sales and...

JNJ : 157.37 (+0.29%)
KVUE : 23.01 (+3.32%)
AMGN : 276.85 (+1.16%)
If Your Portfolio Is Down on the Tariff News, Check Out This Little-Known High-Yield Dividend Stock

Investors are dumping growth stocks right now as new tariff policies rock the markets.

COMP : 7.02 (+2.33%)
JNJ : 157.37 (+0.29%)
KVUE : 23.01 (+3.32%)
SPY : 526.94 (+2.54%)
Kenvue: Iconic Brands, but Struggling to Grow

Explore the exciting world of Kenvue (NYSE: KVUE) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment...

NVDA : 98.94 (+2.09%)
KVUE : 23.01 (+3.32%)
Neutrogena® and John Cena Team Up for the Ultimate Disappearing Act in New Ultra Sheer ® Mineral Sunscreen Campaign

/CNW/ -- Kenvue Inc. (NYSE: KVUE) continues to push the boundaries of suncare product development with the launch of the Neutrogena® Ultra Sheer ® Face Liquid...

KVUE : 23.01 (+3.32%)
My Top High-Yield Dividend Stock to Buy in April (and It's Not Even Close)

Nearly a quarter through 2025, the S&P 500 (SNPINDEX: ^GSPC) is down year to date -- a noticeable step change after the index posted back-to-back 20% annual gains in 2023 and 2024.

TGT : 95.19 (+1.50%)
KMB : 137.78 (-1.63%)
HRL : 30.63 (+0.76%)
KO : 73.92 (+1.58%)
$SPX : 5,300.15 (+2.75%)
LANC : 192.77 (+1.36%)
CL : 95.84 (+1.20%)
SYY : 73.25 (+2.53%)
PG : 168.01 (+1.36%)
KVUE : 23.01 (+3.32%)
PEP : 143.61 (+1.33%)
WMT : 94.95 (+2.75%)
Here's How to Play JNJ Stock as it Announces $55B US Investment Plan

Last week, J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States as the Trump administration considers imposing tariffs...

ITCI : 131.87 (-0.04%)
JNJ : 157.37 (+0.29%)
KVUE : 23.01 (+3.32%)
AMGN : 276.85 (+1.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.

See More

Key Turning Points

3rd Resistance Point 24.45
2nd Resistance Point 23.92
1st Resistance Point 23.09
Last Price 23.01
1st Support Level 21.73
2nd Support Level 21.20
3rd Support Level 20.37

See More

52-Week High 24.46
Last Price 23.01
Fibonacci 61.8% 21.87
Fibonacci 50% 21.06
Fibonacci 38.2% 20.26
52-Week Low 17.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro